ATH 0.00% 0.4¢ alterity therapeutics limited

PBT434 inhibits alpha- synuclein in the brain., page-21

  1. 5,897 Posts.
    lightbulb Created with Sketch. 151
    This may help. [The affinity of PBT434 for iron is greater than that of alpha-synuclein but lower than that of endogenous iron trafficking proteins, e.g., ferritin.]
    https://www.mdsabstracts.org/abstract/pbt434-prevents-the-accumulation-of-glial-cell-inclusions-and-insoluble-alpha-synuclein-in-a-mouse-model-of-multiple-system-atrophy/
    So tightly bound stores of iron are not touched by PBT434. Only free and lightly attached iron is effected by PBT434. By that MOA PBT434 is able to remove the problem iron with no chance of causing undesirable effects of clawing iron from tightly held iron stores like ferritin.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $5.012K 1.294M

Buyers (Bids)

No. Vol. Price($)
43 54662006 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126993867 29
View Market Depth
Last trade - 16.10pm 28/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.